Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
Collagens are a primary component of the extracellular matrix and are functional ligands for the inhibitory immune receptor leukocyte-associated immunoglobulin-like receptor (LAIR)-1. LAIR-2 is a secreted protein that can act as a decoy receptor by binding collagen with higher affinity than LAIR-1....
Príomhchruthaitheoirí: | M Ines Pascoal Ramos, Linjie Tian, Emma J de Ruiter, Chang Song, Ana Paucarmayta, Akashdip Singh, Eline Elshof, Saskia V Vijver, Jahangheer Shaik, Jason Bosiacki, Zachary Cusumano, Christina Jensen, Nicholas Willumsen, Morten A Karsdal, Linda Liu, Sol Langermann, Stefan Willems, Dallas Flies, Linde Meyaard |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
eLife Sciences Publications Ltd
2021-06-01
|
Sraith: | eLife |
Ábhair: | |
Rochtain ar líne: | https://elifesciences.org/articles/62927 |
Míreanna comhchosúla
Míreanna comhchosúla
-
LAIR-1 Limits Neutrophilic Airway Inflammation
de réir: Kuldeep Kumawat, et al.
Foilsithe / Cruthaithe: (2019-04-01) -
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1
de réir: Saskia V. Vijver, et al.
Foilsithe / Cruthaithe: (2021-10-01) -
Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1
de réir: Lijun Xu, et al.
Foilsithe / Cruthaithe: (2020-01-01) -
445 Blockade of the inhibitory collagen receptor LAIR-1 with NC410, a LAIR2-Fc fusion protein, enhances anti-tumor activity of the bifunctional fusion protein bintrafusp alfa
de réir: Jeffrey Schlom, et al.
Foilsithe / Cruthaithe: (2020-11-01) -
694 NC410 is a novel immunomedicine for the treatment of solid tumors
de réir: Linde Meyaard, et al.
Foilsithe / Cruthaithe: (2020-11-01)